KCM
ABBV icon

Key Capital Management’s AbbVie ABBV Stock Holding History

Key Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.2K Sell
283
-106
-27% -$22.8K 0.04% 134
2026
Q1 		$84.6K Buy
389
+81
+26% +$18K 0.06% 109
2025
Q4 		$70.4K Buy
+308
New +$70.2K 0.07% 109

Other funds holding ABBV

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Key Capital Management's ABBV Position: Q2 2026 in Review

Key Capital Management reduced its AbbVie (ABBV) stake by 27% in Q2 2026, selling an estimated $22.8K and leaving 283 shares worth $71.2K. The position accounts for 0.04% of the portfolio, ranked #134.

Key Capital Management first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $84.6K in Q1 2026. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Key Capital Management held 283 shares of AbbVie worth $71.2K as of Q2 2026.
  • Key Capital Management sold 106 AbbVie shares in Q2 2026, an estimated $22.8K.
  • AbbVie made up 0.04% of Key Capital Management's portfolio in Q2 2026, its #134 holding.
  • Key Capital Management first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Key Capital Management's AbbVie position peaked at $84.6K in Q1 2026.
  • 2,655 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Key Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.